share_log

Needham Upgrades Collegium Pharmaceutical to Buy, Announces $46 Price Target

Needham Upgrades Collegium Pharmaceutical to Buy, Announces $46 Price Target

Needham将Collegium Pharmaceutical评级上调为买入,并宣布46美元的目标价格
Benzinga ·  01/10 19:50  · 评级/大行评级

Needham analyst Serge Belanger upgrades Collegium Pharmaceutical (NASDAQ:COLL) from Hold to Buy and announces $46 price target.

Needham 分析师Serge Belanger将Collegium Pharmaceutical(纳斯达克:COLL)从持有评级上调至买入,并宣布目标价为46美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发